A Study of Herceptin (Trastuzumab) Monotherapy in Patients With Metastatic Urothelial Cancer

Clinical trial NCT02013765 · TERMINATED

Trial details

NCT number: NCT02013765
Sponsor: Hoffmann-La Roche
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Urinary Tract Cancer

Start date: 2001-01-01
Primary completion: 2010-01-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.